These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34331656)

  • 1. Functional and Anatomical Characterization of Corticotropin-Releasing Factor Receptor Subtypes of the Rat Spinal Cord Involved in Somatic Pain Relief.
    Mousa SA; Shaqura M; Khalefa BI; Li L; Al-Madol M; Treskatsch S; Schäfer M
    Mol Neurobiol; 2021 Nov; 58(11):5459-5472. PubMed ID: 34331656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas.
    Mousa SA; Khalefa BI; Shaqura M; Al-Madol M; Treskatsch S; Schäfer M
    J Neuroinflammation; 2022 Jun; 19(1):148. PubMed ID: 35705992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of inflammatory pain by CRF at peripheral, spinal and supraspinal sites: involvement of areas coexpressing CRF receptors and opioid peptides.
    Mousa SA; Bopaiah CP; Richter JF; Yamdeu RS; Schäfer M
    Neuropsychopharmacology; 2007 Dec; 32(12):2530-42. PubMed ID: 17375137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain.
    Mousa SA; Bopaiah PC; Stein C; Schäfer M
    Pain; 2003 Dec; 106(3):297-307. PubMed ID: 14659512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.
    Larson AA; Nunez MG; Kissel CL; Kovács KJ
    Eur J Neurosci; 2015 Nov; 42(10):2772-82. PubMed ID: 26332847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peripheral corticotropin-releasing factor (CRF)-induced analgesic effect on somatic pain sensitivity in conscious rats: involving CRF, opioid and glucocorticoid receptors.
    Yarushkina NI; Filaretova LP
    Inflammopharmacology; 2018 Apr; 26(2):305-318. PubMed ID: 29404882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Footshock-induced urinary bladder hypersensitivity: role of spinal corticotropin-releasing factor receptors.
    Robbins MT; Ness TJ
    J Pain; 2008 Nov; 9(11):991-8. PubMed ID: 18632307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effects of endomorphin-2: suppression of substance P release in the inflammatory pain model rat.
    Wu XN; Zhang T; Qian NS; Guo XD; Yang HJ; Huang KB; Luo GQ; Xiang W; Deng WT; Dai GH; Peng KR; Pan SY
    Neurochem Int; 2015 Mar; 82():1-9. PubMed ID: 25661513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.
    Schäfer M; Carter L; Stein C
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4219-23. PubMed ID: 7910403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
    J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons.
    Budai D; Fields HL
    J Neurophysiol; 1998 Feb; 79(2):677-87. PubMed ID: 9463431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoactivation of CRF receptors, predominantly type 2, in the medial-posterior BNST is vital for adequate maternal behavior in lactating rats.
    Klampfl SM; Brunton PJ; Bayerl DS; Bosch OJ
    J Neurosci; 2014 Jul; 34(29):9665-76. PubMed ID: 25031406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice.
    Song ZH; Takemori AE
    J Pharmacol Exp Ther; 1990 Aug; 254(2):363-8. PubMed ID: 2166788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-Releasing Factor in the Brain and Blocking Spinal Descending Signals Induce Hyperalgesia in the Latent Sensitization Model of Chronic Pain.
    Chen W; Taché Y; Marvizón JC
    Neuroscience; 2018 Jun; 381():149-158. PubMed ID: 29776484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression.
    Gogas KR; Presley RW; Levine JD; Basbaum AI
    Neuroscience; 1991; 42(3):617-28. PubMed ID: 1659673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions.
    Pernar L; Curtis AL; Vale WW; Rivier JE; Valentino RJ
    J Neurosci; 2004 Feb; 24(6):1305-11. PubMed ID: 14960601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues.
    Baigent SM; Lowry PJ
    J Mol Endocrinol; 2000 Aug; 25(1):43-52. PubMed ID: 10915217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
    Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
    Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An artificial peptide with corticotropin-releasing factor receptor-2 (CRF-R2) selective properties: the role of primary structure in the induction of signal transduction pathways.
    Tellam DJ; Smart D; Qian X; Lovejoy DA
    J Pept Res; 2002 Oct; 60(4):215-22. PubMed ID: 12366528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.